Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jin-shui Huan-xian Formula in Idiopathic Pulmonary Fibrosis
NCT06914713Recruiting
- Sponsor
- Henan University of Chinese Medicine
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, triple-blind trial in idiopathic pulmonary fibrosis (IPF) comparing Jin-shui Huan-xian Formula with Placebo (2 arms). Primary endpoint: Forced vital capacity at 52 weeks. Started Sep 2025; status: recruiting.
02
Drugs
Jinshui Huanxian
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT06914713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06914713.